Guest guest Posted February 12, 2010 Report Share Posted February 12, 2010 <http://www.americanchronicle.com/> Fri Feb 12 2010 21:51:39 GMT-0600 (Central Standard Time) Vaccine Adjuvant Alters Neurological Function in Rat Experiment, Symptoms Identical to Autism Lourdes Salvador November 30, 2009 Autism is a neurodevelopmental disability characterized by social withdrawal, communication deficits, and repetitive behaviors. Both genetic and environmental factors have been implicated as causes of autism, moreover a high body burden of mercury and other toxic metals from vaccinations and environmental exposures has been increasingly given more attention. Thimerosal is mercury containing vaccine preservative added to many childhood vaccines. It is widely suspected as a cause of an increasing widespread epidemic of childhood neurodevelopmental disorders such as autism. Now, a new study shows that administration of thimerosal leads to long lasting neurological impairment in rats, specifically by altering the neural process of handling noxious stimuli. Analysis also shows that significant amounts of mercury from thimerosal accumulates in the rat brain and remains long term. The mercury is not readily cleared, as was previously believed. Though mercury readily leaves the blood stream, it does not leave the body. It is now recognized to accumulate in brain tissue. Additionally, this research is supported by various prior studies which show that children with autism suffer from a weak ability to excrete mercury and that the weaker the ability, the more severe the symptoms of autism. Now, two new research studies investigating the effects of chelation therapy on the health and behavior of children with autism spectrum disorders have discovered that children receiving chelation to reduce mercury levels had significant improvements. It appears that mercury may produce they symptom set recognized in the autism spectrum disorders as a form of autism. *References* JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part A--medical results. BMC Clin Pharmacol. 2009 Oct 23;9:16. JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. BMC Clin Pharmacol. 2009 Oct 23;9:17. Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res. 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. This article originally appeared in the MCS America News, December 2009 Issue http://mcs-america.org/december2009.pdf. For more articles on this topic, see: MCSA News<http://mcs-america.org/index_files/newsletterarchives.htm> .. Copyrighted 2009 Lourdes Salvador & MCS America Regards, Summer McFarland 1.22 HEAL KIDS 1.224.325.5437 --------------------------------------------------------------------------------\ ------------------------------------- Over fourteen years of organic search engine optimization, marketing and design. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2010 Report Share Posted February 13, 2010 Does anyone have a copy of the whole paper? J > > <http://www.americanchronicle.com/> > Fri Feb 12 2010 21:51:39 GMT-0600 (Central Standard Time) > Vaccine Adjuvant Alters Neurological Function in Rat Experiment, Symptoms > Identical to Autism > Lourdes Salvador > November 30, 2009 > Autism is a neurodevelopmental disability characterized by social > withdrawal, communication deficits, and repetitive behaviors. Both genetic > and environmental factors have been implicated as causes of autism, moreover > a high body burden of mercury and other toxic metals from vaccinations and > environmental exposures has been increasingly given more attention. > > Thimerosal is mercury containing vaccine preservative added to many > childhood vaccines. It is widely suspected as a cause of an increasing > widespread epidemic of childhood neurodevelopmental disorders such as > autism. > > Now, a new study shows that administration of thimerosal leads to long > lasting neurological impairment in rats, specifically by altering the neural > process of handling noxious stimuli. > > Analysis also shows that significant amounts of mercury from thimerosal > accumulates in the rat brain and remains long term. The mercury is not > readily cleared, as was previously believed. Though mercury readily leaves > the blood stream, it does not leave the body. It is now recognized to > accumulate in brain tissue. > > Additionally, this research is supported by various prior studies which show > that children with autism suffer from a weak ability to excrete mercury and > that the weaker the ability, the more severe the symptoms of autism. > > Now, two new research studies investigating the effects of chelation therapy > on the health and behavior of children with autism spectrum disorders have > discovered that children receiving chelation to reduce mercury levels had > significant improvements. > > It appears that mercury may produce they symptom set recognized in the > autism spectrum disorders as a form of autism. > > *References* > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part A--medical results. BMC Clin Pharmacol. 2009 Oct 23;9:16. > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part B - behavioral results. BMC Clin Pharmacol. 2009 Oct 23;9:17. > > Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration > of a vaccine preservative, thimerosal, produces lasting impairment of > nociception and apparent activation of opioid system in rats. Brain Res. > 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. > > This article originally appeared in the MCS America News, December 2009 > Issue http://mcs-america.org/december2009.pdf. For more articles on this > topic, see: MCSA News<http://mcs-america.org/index_files/newsletterarchives.htm> > . > > Copyrighted 2009 Lourdes Salvador & MCS America > > Regards, > > Summer McFarland > 1.22 HEAL KIDS > 1.224.325.5437 > --------------------------------------------------------------------------------\ ------------------------------------- > Over fourteen years of organic search engine optimization, marketing and > design. > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2010 Report Share Posted February 13, 2010 Here: http://mcs-america.org/december2009.pdf page 25 [ ] Re: Thimerosal Rat Study, Symptoms Identical to Autism Does anyone have a copy of the whole paper? J > > <http://www.americanchronicle.com/> > Fri Feb 12 2010 21:51:39 GMT-0600 (Central Standard Time) > Vaccine Adjuvant Alters Neurological Function in Rat Experiment, Symptoms > Identical to Autism > Lourdes Salvador > November 30, 2009 > Autism is a neurodevelopmental disability characterized by social > withdrawal, communication deficits, and repetitive behaviors. Both genetic > and environmental factors have been implicated as causes of autism, moreover > a high body burden of mercury and other toxic metals from vaccinations and > environmental exposures has been increasingly given more attention. > > Thimerosal is mercury containing vaccine preservative added to many > childhood vaccines. It is widely suspected as a cause of an increasing > widespread epidemic of childhood neurodevelopmental disorders such as > autism. > > Now, a new study shows that administration of thimerosal leads to long > lasting neurological impairment in rats, specifically by altering the neural > process of handling noxious stimuli. > > Analysis also shows that significant amounts of mercury from thimerosal > accumulates in the rat brain and remains long term. The mercury is not > readily cleared, as was previously believed. Though mercury readily leaves > the blood stream, it does not leave the body. It is now recognized to > accumulate in brain tissue. > > Additionally, this research is supported by various prior studies which show > that children with autism suffer from a weak ability to excrete mercury and > that the weaker the ability, the more severe the symptoms of autism. > > Now, two new research studies investigating the effects of chelation therapy > on the health and behavior of children with autism spectrum disorders have > discovered that children receiving chelation to reduce mercury levels had > significant improvements. > > It appears that mercury may produce they symptom set recognized in the > autism spectrum disorders as a form of autism. > > *References* > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part A--medical results. BMC Clin Pharmacol. 2009 Oct 23;9:16. > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part B - behavioral results. BMC Clin Pharmacol. 2009 Oct 23;9:17. > > Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration > of a vaccine preservative, thimerosal, produces lasting impairment of > nociception and apparent activation of opioid system in rats. Brain Res. > 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. > > This article originally appeared in the MCS America News, December 2009 > Issue http://mcs-america.org/december2009.pdf. For more articles on this > topic, see: MCSA News<http://mcs-america.org/index_files/newsletterarchives.htm> > . > > Copyrighted 2009 Lourdes Salvador & MCS America > > Regards, > > Summer McFarland > 1.22 HEAL KIDS > 1.224.325.5437 > ---------------------------------------------------------- > Over fourteen years of organic search engine optimization, marketing and > design. > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2010 Report Share Posted February 13, 2010 Excuse my previous message --I messed up the links. That article refers to two studies: 1. JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: BMC Clin Pharmacol. 2009 Oct 23;9:16. Part A--medical results: http://www.biomedcentral.com/content/pdf/1472-6904-9-16.pdf Part B --Behavioral results: http://www.biomedcentral.com/content/pdf/1472-6904-9-17.pdf 2. Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res. 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. You need a Science Direct account to get full access; the abstract is here: http://www.sciencedirect.com/science?_ob=ArticleURL & _udi=B6SYR-4X66S64-2 & _user=1\ 0 & _coverDate=11%2F16%2F2009 & _rdoc=1 & _fmt=high & _orig=search & _sort=d & _docanchor= & v\ iew=c & _acct=C000050221 & _version=1 & _urlVersion=0 & _userid=10 & md5=0b6ea4e949c02afff\ 61e8c19552755d5 Hope it helps. > [ ] Re: Thimerosal Rat Study, Symptoms Identical to Autism Does anyone have a copy of the whole paper? J > > <http://www.americanchronicle.com/> > Fri Feb 12 2010 21:51:39 GMT-0600 (Central Standard Time) > Vaccine Adjuvant Alters Neurological Function in Rat Experiment, Symptoms > Identical to Autism > Lourdes Salvador > November 30, 2009 > Autism is a neurodevelopmental disability characterized by social > withdrawal, communication deficits, and repetitive behaviors. Both genetic > and environmental factors have been implicated as causes of autism, moreover > a high body burden of mercury and other toxic metals from vaccinations and > environmental exposures has been increasingly given more attention. > > Thimerosal is mercury containing vaccine preservative added to many > childhood vaccines. It is widely suspected as a cause of an increasing > widespread epidemic of childhood neurodevelopmental disorders such as > autism. > > Now, a new study shows that administration of thimerosal leads to long > lasting neurological impairment in rats, specifically by altering the neural > process of handling noxious stimuli. > > Analysis also shows that significant amounts of mercury from thimerosal > accumulates in the rat brain and remains long term. The mercury is not > readily cleared, as was previously believed. Though mercury readily leaves > the blood stream, it does not leave the body. It is now recognized to > accumulate in brain tissue. > > Additionally, this research is supported by various prior studies which show > that children with autism suffer from a weak ability to excrete mercury and > that the weaker the ability, the more severe the symptoms of autism. > > Now, two new research studies investigating the effects of chelation therapy > on the health and behavior of children with autism spectrum disorders have > discovered that children receiving chelation to reduce mercury levels had > significant improvements. > > It appears that mercury may produce they symptom set recognized in the > autism spectrum disorders as a form of autism. > > *References* > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part A--medical results. BMC Clin Pharmacol. 2009 Oct 23;9:16. > > JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, > Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and > efficacy of oral DMSA therapy for children with autism spectrum disorders: > part B - behavioral results. BMC Clin Pharmacol. 2009 Oct 23;9:17. > > Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration > of a vaccine preservative, thimerosal, produces lasting impairment of > nociception and apparent activation of opioid system in rats. Brain Res. > 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. > > This article originally appeared in the MCS America News, December 2009 > Issue http://mcs-america.org/december2009.pdf. For more articles on this > topic, see: MCSA News<http://mcs-america.org/index_files/newsletterarchives.htm> > . > > Copyrighted 2009 Lourdes Salvador & MCS America > > Regards, > > Summer McFarland > 1.22 HEAL KIDS > 1.224.325.5437 > ---------------------------------------------------------- > Over fourteen years of organic search engine optimization, marketing and > design. > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 13, 2010 Report Share Posted February 13, 2010 Excuse my previous message --I messed up the links. That article refers to two studies: 1. JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: BMC Clin Pharmacol. 2009 Oct 23;9:16. Part A--medical results: http://www.biomedcentral.com/content/pdf/1472-6904-9-16.pdf Part B --Behavioral results: http://www.biomedcentral.com/content/pdf/1472-6904-9-17.pdf 2. Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res. 2009 Dec 8;1301:143-51. Epub 2009 Sep 9. You need a Science Direct account to get full access; the abstract is here: http://www.sciencedirect.com/science?_ob=ArticleURL & _udi=B6SYR-4X66S64-2 & _user=1\ 0 & _coverDate=11%2F16%2F2009 & _rdoc=1 & _fmt=high & _orig=search & _sort=d & _docanchor= & v\ iew=c & _acct=C000050221 & _version=1 & _urlVersion=0 & _userid=10 & md5=0b6ea4e949c02afff\ 61e8c19552755d5 Hope it helps. > [ ] Re: Thimerosal Rat Study, Symptoms Identical to Autism Does anyone have a copy of the whole paper? J Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 14, 2010 Report Share Posted February 14, 2010 Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Olczak M, Duszczyk M, Mierzejewski P, Majewska MD. http://www.ncbi.nlm.nih.gov/pubmed/19747466 Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. BMC Clin Pharmacol. 2009 Oct 23;9:17. http://www.ncbi.nlm.nih.gov/pubmed/19852790?itool=EntrezSystem2.PEntrez.Pubmed.P\ ubmed_ResultsPanel.Pubmed_RVDocSum & ordinalpos=1 JB, Baral M, Geis E, J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, K, Bradstreet J, El-Dahr J. BMC Clin Pharmacol. 2009 Oct 23;9:16. http://www.ncbi.nlm.nih.gov/pubmed/19852789?itool=EntrezSystem2.PEntrez.Pubmed.P\ ubmed_ResultsPanel.Pubmed_RVDocSum & ordinalpos=2 Regards, Summer McFarland 1.22 HEAL KIDS 1.224.325.5437 --------------------------------------------------------------------------------\ ------------------------------------- Over fourteen years of organic search engine optimization, marketing and design. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.